These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15843667)

  • 41. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group.
    Gurfinkel E; Bozovich G; Daroca A; Beck E; Mautner B
    Lancet; 1997 Aug; 350(9075):404-7. PubMed ID: 9259655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The failure of antibiotics to prevent heart attacks.
    Taylor-Robinson D; Boman J
    BMJ; 2005 Aug; 331(7513):361-2. PubMed ID: 16096289
    [No Abstract]   [Full Text] [Related]  

  • 43. Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial.
    Jespersen CM; Als-Nielsen B; Damgaard M; Hansen JF; Hansen S; Helø OH; Hildebrandt P; Hilden J; Jensen GB; Kastrup J; Kolmos HJ; Kjøller E; Lind I; Nielsen H; Petersen L; Gluud C;
    BMJ; 2006 Jan; 332(7532):22-7. PubMed ID: 16339220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
    Ridker PM; Everett BM; Thuren T; MacFadyen JG; Chang WH; Ballantyne C; Fonseca F; Nicolau J; Koenig W; Anker SD; Kastelein JJP; Cornel JH; Pais P; Pella D; Genest J; Cifkova R; Lorenzatti A; Forster T; Kobalava Z; Vida-Simiti L; Flather M; Shimokawa H; Ogawa H; Dellborg M; Rossi PRF; Troquay RPT; Libby P; Glynn RJ;
    N Engl J Med; 2017 Sep; 377(12):1119-1131. PubMed ID: 28845751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.
    Anderson JL; Muhlestein JB; Carlquist J; Allen A; Trehan S; Nielson C; Hall S; Brady J; Egger M; Horne B; Lim T
    Circulation; 1999 Mar; 99(12):1540-7. PubMed ID: 10096928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
    Tardif JC; Kouz S; Waters DD; Bertrand OF; Diaz R; Maggioni AP; Pinto FJ; Ibrahim R; Gamra H; Kiwan GS; Berry C; López-Sendón J; Ostadal P; Koenig W; Angoulvant D; Grégoire JC; Lavoie MA; Dubé MP; Rhainds D; Provencher M; Blondeau L; Orfanos A; L'Allier PL; Guertin MC; Roubille F
    N Engl J Med; 2019 Dec; 381(26):2497-2505. PubMed ID: 31733140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relation of antibiotic use to risk of myocardial infarction in the general population.
    Luchsinger JA; Pablos-Méndez A; Knirsch C; Rabinowitz D; Shea S
    Am J Cardiol; 2002 Jan; 89(1):18-21. PubMed ID: 11779516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of IgG-seropositivity to Chlamydia pneumoniae in early thrombotic events after coronary stent placement.
    da Costa CP; Neumann FJ; Kastrati A; Stallforth I; Schmid M; Joghetai N; Prebeck S; Wagner H; Miethke T
    Atherosclerosis; 2003 Jan; 166(1):171-6. PubMed ID: 12482564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibiotic therapy after acute myocardial infarction: a prospective randomized study.
    Zahn R; Schneider S; Frilling B; Seidl K; Tebbe U; Weber M; Gottwik M; Altmann E; Seidel F; Rox J; Höffler U; Neuhaus KL; Senges J;
    Circulation; 2003 Mar; 107(9):1253-9. PubMed ID: 12628944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome.
    Sinisalo J; Mattila K; Valtonen V; Anttonen O; Juvonen J; Melin J; Vuorinen-Markkola H; Nieminen MS;
    Circulation; 2002 Apr; 105(13):1555-60. PubMed ID: 11927522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study.
    Gurfinkel E; Bozovich G; Beck E; Testa E; Livellara B; Mautner B
    Eur Heart J; 1999 Jan; 20(2):121-7. PubMed ID: 10099908
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chlamydia pneumoniae and acute coronary syndrome.
    Mitchell WM; Stratton CW
    N Engl J Med; 2005 Aug; 353(5):525-8; author reply 525-8. PubMed ID: 16080250
    [No Abstract]   [Full Text] [Related]  

  • 53. Chronic infections and coronary heart disease.
    Anestad G; Scheel O; Hungnes O
    Lancet; 1997 Oct; 350(9083):1028; author reply 1029. PubMed ID: 9329529
    [No Abstract]   [Full Text] [Related]  

  • 54. [Meta-analysis of randomized trials of antimicrobial drugs in the treatment of coronary heart disease].
    Skochko OV; Kaĭdashev IP
    Lik Sprava; 2012; (5):72-86. PubMed ID: 23534274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. n-3 fatty acids in patients with multiple cardiovascular risk factors.
    ; Roncaglioni MC; Tombesi M; Avanzini F; Barlera S; Caimi V; Longoni P; Marzona I; Milani V; Silletta MG; Tognoni G; Marchioli R
    N Engl J Med; 2013 May; 368(19):1800-8. PubMed ID: 23656645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial.
    Wiesli P; Czerwenka W; Meniconi A; Maly FE; Hoffmann U; Vetter W; Schulthess G
    Circulation; 2002 Jun; 105(22):2646-52. PubMed ID: 12045171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotics for coronary disease: it's time to move on.
    Conti CR
    Clin Cardiol; 2004 Dec; 27(12):669. PubMed ID: 15628106
    [No Abstract]   [Full Text] [Related]  

  • 58. Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease.
    Dugan JP; Feuge RR; Burgess DS
    Clin Ther; 2002 May; 24(5):719-35. PubMed ID: 12075941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The role of inflammation and infection in acute coronary syndrome].
    Blankenberg S; Rupprecht HJ; Bickel C; Hafner G; Meyer J
    Herz; 2001 Apr; 26 Suppl 1():9-18. PubMed ID: 11349630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotics against Chlamydia pneumoniae and prognosis after acute myocardial infarction.
    Pilote L; Green L; Joseph L; Richard H; Eisenberg MJ
    Am Heart J; 2002 Feb; 143(2):294-300. PubMed ID: 11835034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.